DarioHealth Corp.
DRIO | NASDAQ
$7.07
-$0.13 (-1.81%)
At close: Sep 21, 2026, 4:00 PM ET
$6.95
-$0.12 (-1.70%)
After-hours:
Sep 21, 2026, 4:27 PM ET
Market Data
Market Cap $52.64M
Enterprise Value $69.85M
Beta 1.12
Average Volume 17.73K
Shares Outstanding (Diluted) 9.34M
Shares Change YoY -81.17%
Institutional Ownership 9.02%
Exchange NASDAQ
ISIN US23725P3082
Price Performance
Price Change 1M -5.5%
Price Change 3M 18.0%
Price Change 6M -8.2%
Price Change YTD -32.8%
Price Change 1Y -9.1%
Price Change 3Y -88.9%
Price Change 5Y -97.5%
1M CAGR (ann.) -7.1%
1Y CAGR (ann.) 9.4%
5Y CAGR (ann.) -51.2%
All-Time CAGR -39.6%
Valuation
PE Ratio 10.25
Forward PE N/A
PEG Ratio 0.11
Forward PEG -0.28
PS Ratio 2.46
Forward PS 1.80
PB Ratio 0.94
P/FCF Ratio -2.08
P/Adj. FCF Ratio -1.78
P/OCF Ratio -2.67
EV/Sales 3.33
EV/EBIT -2.21
EV/EBITDA -2.35
EV/FCF -2.81
Earnings Yield 9.8%
FCF Yield -48.1%
Adj. FCF Yield -56.1%
Financial Health
Net Debt $17.38M
Total Debt $32.41M
Cash & Short-Term Investments $14.25M
Total Assets $96.59M
Current Ratio 2.31
Quick Ratio 1.92
Debt / Equity Ratio 0.59
Debt / EBITDA -1.09
Debt / FCF -1.30
OCF / Debt -0.76
Interest Coverage -12.35
Altman Z-Score -6.73
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 56.1%
Operating Profit Margin -328.8%
EBITDA Margin -141.7%
Net Profit Margin 322.8%
FCF Margin -118.5%
Adj. FCF Margin -138.1%
SBC / Revenue 19.6%
SBC Impact (per share) -16.5%
Returns
Return on Assets 70.2%
Return on Equity 104.2%
Return on Invested Capital -78.4%
Return on Capital Employed -79.4%
Return on Tangible Assets 280.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -7.6%
Revenue CAGR 5Y 10.1%
Revenue CAGR 10Y 27.7%
EPS CAGR 3Y 185.1%
EPS CAGR 5Y 69.4%
EPS CAGR 10Y 38.9%
FCF CAGR 3Y 25.9%
FCF CAGR 5Y 19.4%
FCF CAGR 10Y -10.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y -110.1%
Revenue Growth Next 3Y 26.0%
Earnings Date Nov 11, 2026
EPS Estimate (next Q) -$0.51
EPS Growth Est (next Q) -72.4%
Revenue Est (next Q) $5.24M
Revenue Growth Est (next Q) 4.7%
Fair Value Estimates
Graham Number $9.57
Graham Upside 35.4%
Lynch Fair Value $17.25
Lynch Upside 144.0%
Price Target $12.50
Price Target Upside 76.8%
Cash Flow
Operating Cash Flow $-24.76M
Free Cash Flow $-24.89M
Adj. Free Cash Flow $-29M
FCF Per Share -$2.66
OCF Per Share -$2.65
OCF/S Ratio -117.9%
Income Statement
Revenue $21M
Gross Profit $11.78M
Operating Income $-69.05M
EBITDA $-29.75M
Net Income $67.78M
EPS (Diluted) $0.69
Revenue / Employee $128.83K
Profit / Employee $415.82K
Employees 163
Add to Watchlist
Select watchlists to add or remove DRIO